Clinical trial
Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma…
NCT00126269 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Unknown status
Key facts
| NCT number | NCT00126269 |
|---|---|
| Title | Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary |
| Official title | A Randomized Phase III Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary and a Predicted Favorable Prognosis |
| Lead sponsor | Gustave Roussy, Cancer Campus, Grand Paris, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Carcinoma |
| Intervention type | Drug |
| Interventions | cisplatin, gemcitabine |
| Enrollment | 192 |
| Start date | May 1, 2003 |
| First posted | Aug 3, 2005 |
| Last update posted | Sep 8, 2006 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: